Testosterone Replacement Therapy and Cardiovascular Risk-A Closer Look to Additional Parameters

T Craig Cheetham^{1

2}, Stephen K VanDenEeden³, Steven J Jacobsen¹

Affiliations

¹ Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena.
² Visiting Scholar, Western University-College of Pharmacy, Pomona, California.
³ Division of Research, Kaiser Permanente Northern California, Oakland.

Comment

T Craig Cheetham et al. JAMA Intern Med. 2017.

. 2017 Sep 1;177(9):1393-1394.

doi: 10.1001/jamainternmed.2017.3890.

T Craig Cheetham^{1

2}, Stephen K VanDenEeden³, Steven J Jacobsen¹

¹ Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena.
² Visiting Scholar, Western University-College of Pharmacy, Pomona, California.
³ Division of Research, Kaiser Permanente Northern California, Oakland.

No abstract available

Comment on

Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
Cheetham TC, An J, Jacobsen SJ, Niu F, Sidney S, Quesenberry CP, VanDenEeden SK. Cheetham TC, et al. JAMA Intern Med. 2017 Apr 1;177(4):491-499. doi: 10.1001/jamainternmed.2016.9546. JAMA Intern Med. 2017. PMID: 28241244
Testosterone Replacement Therapy and Cardiovascular Risk-A Closer Look at Additional Parameters.
Stavropoulos K, Imprialos KP, Doumas M. Stavropoulos K, et al. JAMA Intern Med. 2017 Sep 1;177(9):1393. doi: 10.1001/jamainternmed.2017.3154. JAMA Intern Med. 2017. PMID: 28873188 No abstract available.